iBio, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Development Agreements (2)
- Indemnification Agreements (2)
- Settlement Agreements (1)
- Termination Agreements (1)
- Voting Agreements (2)
- Termination Agreement and Release dated September 19, 2022 by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on November 14, 2022)
- Form of Irrevocable Proxy For Voting Control (Filed With SEC on May 12, 2022)
- Confidential Settlement and Mutual Release with Fraunhofer USA, Inc. dated May 4, 2021 (Filed With SEC on September 28, 2021)
- Second Amended and Restated Voting Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)
- Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
- Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
- Indemnification Agreement by and between iBio, Inc., John Delta and TechCXO, LLC dated July 13, 2020 (Filed With SEC on October 5, 2020)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 19, 2020)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)
- Form of Indemnification Agreement (Filed With SEC on April 1, 2019)
